Logos Global Management »

Trevi Therapeutics shares owned by Logos Global Management

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by Logos Global Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $8.3M 2.8M 2.98
2024-03-31 $7.6M 2.2M 3.45

More positions owned by Logos Global Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Sarepta Therapeutics (SRPT)
Sarepta Therapeutics Call Option (SRPT)
Apellis Pharmaceuticals Call Option (APLS)
Apellis Pharmaceuticals (APLS)
Structure Therapeutics Sponsored Ads Call Option (GPCR)
Structure Therapeutics Sponsored Ads (GPCR)
Ideaya Biosciences (IDYA)
Ideaya Biosciences (IDYA)
Argenx Se Sponsored Adr (ARGX)
Argenx Se Sponsored Adr (ARGX)
Merus N V (MRUS)
Merus N V (MRUS)
Revolution Medicines (RVMD)

View all positions for Logos Global Management

Top funds holding Trevi Therapeutics

NEA Management Company
Frazier Life Sciences Management
Rubric Capital Management
Viking Global Investors
VR Adviser
BlackRock
Logos Global Management
Opaleye Management
Vanguard Group
MPM Oncology Impact Management
MAI Wealth Advisors
Geode Capital Management
State Street Corporation
Silverarc Capital Management
Rosalind Advisors

View all funds holding Trevi Therapeutics